Chemocentryx reported $24.55M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
AstraZeneca AZN:LN 27495M 7363M
Bayer BAYN:GR € 40372M 2493M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Chemocentryx CCXI:US $ 24.55M 0.08M
GlaxoSmithKline GSK:LN 25483M 736M
Glaxosmithkline GSK:US $ 25483M 736M
Johnson & Johnson JNJ:US $ 33483M 130M
Macrogenics MGNX:US $ 0M 0M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 35769M 2030M
Omeros OMER:US $ 312.58M 426K
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Takeda 4502:JP Y 4405861M 4383708M
Teva Pharmaceutical TEVA:IT 25.13B 147M
YTE INCY:US $ 34.25M 0.22M